Table 2. HeLa and MDA-MB-231 Cell Cycle Distribution for after Treatment with CA-4, 4h, and 4s.

	G0/G1 (%)	S (%)	G2/M (%)
HeLa Cells
control (−)	61.60	22.10	15.70
treated with CA-4	37.00	16.70	44.60
treated with 4h	10.30	15.40	73.40
treated with 4s	12.10	17.10	70.60
MDA-MB-231 Cells
control (−)	58.60	25.70	15.50
treated with CA-4	27.50	11.80	57.80
treated with 4h	13.10	16.40	70.50
treated with 4s	18.60	17.10	54.10